Docetaxel, oxaliplatin, leucovorin, and 5-fluorouracil (FLOT) as preoperative and postoperative chemotherapy compared with surgery followed by chemotherapy for patients with locally advanced gastric cancer: a propensity score-based analysis

Introduction: Docetaxel, oxaliplatin, leucovorin, and 5-fluorouracil (FLOT) may improve overall survival (OS) in patients with locally advanced gastric cancer (LAGC); however, evidence for its use as a standard treatment has not been established in China. The aim of this study was to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Keshen, Ren, Yanxian, Ma, Zhijian, Li, Fan, Cheng, Xiaocheng, Xiao, Jingying, Zhang, Shuze, Yu, Zeyuan, Yang, Hanteng, Zhou, Huinian, Li, Yuming, Liu, Hongbin, Jiao, Zuo-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489649/
https://www.ncbi.nlm.nih.gov/pubmed/31114348
http://dx.doi.org/10.2147/CMAR.S200883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489649/
https://www.ncbi.nlm.nih.gov/pubmed/31114348
http://dx.doi.org/10.2147/CMAR.S200883

Ejemplares similares